From: Alexandra Guest Organization(s): Barclays Capital
Comment No: 33804 Date: 3/28/2011
Comment Text:
Attached please find Barclays Capital's comment letter regarding 17 CFR Parts 1, 150 and 151 RIN 3038–AD15 and 3038–AD16 Position Limits for Derivatives.
